Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Stock Statistics & Valuation Metrics

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A has a market cap or net worth of TWD 2.39B. The enterprise value is TWD 2.48B.

Market Cap

TWD 2.39B

Enterprise Value

TWD 2.48B

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A has 76,918,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

76,918,000

Owned by Insiders

―

Owned by Institutions

0.25%

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -7.32%.

Return on Equity (ROE)

-0.08

Return on Assets (ROA)

-0.06

Return on Invested Capital (ROIC)

-7.32%

Return on Capital Employed (ROCE)

-0.08

Revenue Per Employee

3.31M

Profits Per Employee

-1.00M

Employee Count

243

Asset Turnover

0.19

Inventory Turnover

1.13

The current PE Ratio of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A is -33.39. Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s PEG ratio is 0.24.

PE Ratio

-33.39

PS Ratio

2.56

PB Ratio

0.53

Price to FCF

9.61

Price to Operating Cash Flow

5.89

PEG Ratio

0.24

In the last 12 months, Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A had revenue of 804.88M and earned -243.85M in profits. Earnings per share was -4.39.

Revenue

804.88M

Gross Profit

-8.86M

Operating Income

-319.54M

Pretax Income

-255.68M

Net Income

-243.85M

EBITDA

-47.60M

Earnings Per Share (EPS)

-4.39

In the last 12 months, operating cash flow was 290.90M and capital expenditures -42.36M, giving a free cash flow of 248.54M billion.

Operating Cash Flow

290.90M

Free Cash Flow

248.54M

Free Cash Flow per Share

4.51

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A pays an annual dividend of ―, resulting in a dividend yield of 0.62%

Dividend Per Share

―

Dividend Yield

0.62%

Payout Ratio

N/A

Free Cash Flow Yield

10.41%

Earnings Yield

-3.02%

Beta

0.75

52-Week Price Change

24.45%

50-Day Moving Average

33.98

200-Day Moving Average

33.02

Relative Strength Index (RSI)

29.38

Average Volume (3m)

94.48K

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 06, 2026

Next Earnings Date

Nov 16, 2026

Ex-Dividend Date

―

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A as a current ratio of 2.97, with Debt / Equity ratio of 26.10%

Current Ratio

2.97

Quick Ratio

0.96

Debt to Market Cap

0.59

Net Debt to EBITDA

-12.38

Interest Coverage Ratio

-19.10

In the past 12 months, Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A has paid -11.83M in taxes.

Income Tax

-11.83M

Effective Tax Rate

0.05

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A EV to EBITDA ratio is 18.63, with an EV/FCF ratio of 11.32.

EV to Sales

3.01

EV to EBITDA

18.63

EV to Free Cash Flow

11.32

EV to Operating Cash Flow

9.67

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A has TWD 329.96M in cash and marketable securities with TWD 755.63M in debt, giving a net cash position of -TWD 425.68M billion.

Cash & Marketable Securities

TWD 329.96M

Total Debt

TWD 755.63M

Net Cash

-TWD 425.68M

Net Cash Per Share

-TWD 5.53

Tangible Book Value Per Share

TWD 58.05

Gross margin is 17.95%, with operating margin of -14.61%, and net profit margin of -5.53%.

Gross Margin

17.95%

Operating Margin

-14.61%

Pretax Margin

-3.54%

Net Profit Margin

-5.53%

EBITDA Margin

16.17%

EBIT Margin

-3.71%

The average price target for Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-20.25%

EPS Growth Forecast

81.66%